Bristol-Myers Squibb (BMY) posted early gains Monday and climbed for the bulk of the afternoon. The stock finished higher by $0.59 at $25.05. Bristol-Myers Squibb has been on an upward trend since early November and closed Monday at a new high for the year. The company announced after the close Friday that it received FDA approval for the supplemental New Drug Application for ABILIFY, for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.